News Releases

Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application

May 20, 2021

OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie

May 7, 2021

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

April 19, 2021

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

April 5, 2021

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

March 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

March 22, 2021

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

March 22, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

March 12, 2021

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

March 8, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

March 4, 2021

« Previous
1
2
3
4
5
6
7
8
9
10
...21
Next »

Latest News & Events

Dec 8, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

Read More...

Nov 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

Read More...

Oct 31, 2022

Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy

Read More...